Results 141 to 150 of about 128,522 (343)
Chronic Venous Insufficiency With Emphasis on the Geriatric Population. [PDF]
Cureus, 2023 Mayrovitz HN, Aoki KC, Colon J.
europepmc +1 more source
The Impact of Gastrocnemius Muscle Cell Changes in Chronic Venous Insufficiency [PDF]
, 2005 Tiankui Qiao, C. Liu, Feng Ran
openalex +1 more source
Advanced Science, EarlyView.Molecular and functional landscape of BD progression and severity based on in‐depth proteomics. Tree boosting machine learning models with favorable performance in BD diagnosis and stratification. Efficient biomarker panels for BD diagnosis and stratification. .
Linlin Cheng +6 more
wiley +1 more source
Venous Morphology Predicts Class of Chronic Venous Insufficiency
, 1999 Gregory T. Jones +5 more
openalex +1 more source
Advanced Science, EarlyView.The novel microneedle patches (MN@CTB) are fabricated by integrating CTB nanozymes into HAMA and PVA solution based on a photo‐crosslinking reaction. The MN@CTB microneedle patches present an excellent photothermal effect and NIR‐stimulated release of NO, which is advantageous for the elimination of MRS.
Wei Qian +13 more
wiley +1 more source
Femoral canal lipoma presenting as chronic venous insufficiency. [PDF]
J Vasc Surg Cases Innov Tech, 2023 Teh R, Picazo Pineda F, Sieunarine K.
europepmc +1 more source
Advanced Science, EarlyView.CD161 is identified as a novel inhibitory receptor on bone marrow (BM)‐resident CD8⁺ T cells in multiple myeloma (MM). Through interaction with its ligand CLEC2D, CD161 impairs T‐cell function and promotes immune suppression. Blockade of CD161 restores tissue residency and cytotoxicity of CD8⁺ T cells and enhances chimeric antigen receptor T‐cell (CAR ...
Liwen Wang +16 more
wiley +1 more source
Advanced Science, EarlyView.DNA‐based hydrogels serve dual roles as structural scaffolds and therapeutic platforms, offering innovative solutions for musculoskeletal regeneration with multifunctional abilities. Abstract Musculoskeletal disorders, including bone fractures, osteoarthritis, and muscle injuries, represent a leading cause of global disability, revealing the urgency ...
Ruijianghan Shi +4 more
wiley +1 more source
Advanced Science, EarlyView.The cRGD‐ILD molecular probe integrates clinically available components: a cRGD peptide (integrin αvβ3 targeting), ICG (for fluorescence/photoacoustic imaging and phototherapy), and Gd‐DTPA (MRI contrast). Utilizing small size and receptor targeting, it achieves selective lesion accumulation.
Qiyu Zhong +9 more
wiley +1 more source